bit bio
Our breakthrough technology combines synthetic and stem cell biology, offering limitless possibilities. Enabling a new generation of cell therapies, providing the best human cells for research and drug discovery, and allowing the control of advanced synthetic biology circuits for biomanufacturing.
Contact bit bio via their website
News archive
11/02/2021 bit.bio Welcomes New Chief Medical Officer Ramy Ibrahim...more
13/11/2020 bit.bio published in Forbes...more
27/10/2020 bit.bio published in The Times...more
27/10/2020 bit.bio on a moonshot mission with London Institute for Mathematical Sciences...more
11/06/2020 bit bio secures $41.5m funding from top life sciences investors...more
26/02/2020 bit bio Secures Distribution Agreement with Abcam...more
11/12/2019 Charles River Announces Strategic Partnership with bit bio...more
01/12/2019 bit bio joins the BioPartner programme...more
